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Chapter 4 
Copper-Catalyzed Asymmetric 1,2-
Addition of Grignard Reagents to 
Į,ȕ-Unsaturated Ketones  
 
In this chapter, the first copper-catalyzed enantioselective Grignard addition to the 
carbonyl function of Į,ȕ-unsaturated ketones is described. Careful selection of 
copper catalyst and reaction parameters allowed the complete discrimination 
between 1,4-and 1,2-addition of Grignard reagents to enones, with complete 












Parts of this chapter have been published: 
Madduri, A. V. R.; Minnaard, A. J.; Harutyunyan, S. R. Chem. Commun. 2012, 48, 
1478. 








Catalytic asymmetric carbon-carbon bond formation is at the heart of organic 
synthesis.1-3 The catalytic asymmetric addition of organometallic reagents to 
aldehydes and ketones, to afford secondary and tertiary alcohols respectively, is in 
principle one of the most straightforward methods in this field.4-6 In the last two 
decades, the catalytic enantioselective7 alkylation of aldehydes with organometallic 
reagents has seen considerable progress (Scheme 1). In particular organometallic 
reagents based on zinc and titanium have found broad application (Scheme 1 A, 
B).6,8   
 
Scheme 1: 1,2-addition of organometallic reagents to aldehydes  
  
  91 
Asymmetric 1,2-addition of Grignard reagents to enones 
Typically, however, stoichiometric amounts or even an excess of a chiral 
compound is required to achieve high enantioselectivities with the readily 
accessible, but more reactive, Grignard reagents.4,9 Recently the group of Harada 
reported that highly enantioselective catalytic addition of Grignard reagents is 
possible, albeit requiring the use of excess titanium tetraisopropoxide (Scheme 1 
C).10,11 
The catalytic asymmetric addition of organometallic reagents to ketones is 
considerably more challenging than that to aldehydes.  
Scheme 2: Addition of organometallic reagents to ketones 
The difficulties are associated with a significantly diminished reactivity compared to 
aldehydes, a decreased enantiodiscrimination due to the smaller steric and 
electronic differences between the two substituents on the carbonyl group, 
enolisation, and competitive reduction via ȕ-H transfer from the incoming 
nucleophile (Scheme 2).12,13  
Despite the difficulties associated with the 1,2-addition of organometallic reagents 
to ketones, this reaction affords direct access to highly valuable chiral tertiary 














Figure 1: Biologically important compounds with chiral tertiary alcohol functionality: HIV drugs 
and natural products with cytotoxic activity 
Recent advances in this field allowed the catalytic asymmetric 1,2-addition of 
organozinc reagents to ketones, affording enantioenriched tertiary alcohols in  
moderate to high enantioselectivities (Scheme 3).6,12 Being the first, the group of 
Seebach developed a method for the Grignard addition to ketones with two 
equivalents of chiral catalyst (Scheme 3 A).16 Dosa and Fu reported the first 
catalytic asymmetric example of the addition of diphenylzinc to ketones (Scheme 3 
B).17 Shortly thereafter, Yus and coworkers reported the first catalytic asymmetric 
addition of dialkylzinc reagents (Scheme 3 C).18 These initial results inspired the 
design of improved ligands for the asymmetric 1,2-addition of dialkylzinc reagents 
to ketones.19-21 Walsh et al. showed that also Į,ȕ-unsaturated ketones can be 
employed in the 1,2-addition of organozinc reagents.22 A common feature of these 
reactions is the necessity to employ equimolar or excess titanium tetraisopropoxide 
in order to achieve good selectivities. The successful 1,2-addition of organozinc 
reagents to ketones contrasts strongly with the complete absence of a catalytic 
asymmetric 1,2-addition of Grignard reagents, to date.  
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Scheme 3: 1,2-addition of  organometallic to regents ketones  
When organometallic reagents are used in addition reactions to Į,ȕ-unsaturated 
ketones, the regioselectivity (Scheme 4), e.g. 1,4-addition (conjugate addition) 
versus 1,2-addition (direct addition) must be taken into consideration.23 Being hard 
nucleophiles, the tendency of Grignard reagents is to give 1,2-addition.24  
 





After the pioneering work of Gilman in 193625 on the application of organocopper 
compounds in organic synthesis and the discovery of their inherent reactivity 
towards 1,4-addition, copper(I) based reagents and catalysts have been used as 
the major synthetic tool to obtain 1,4-selectivity in addition reactions of 
organometallic reagents.26-29 Currently, a myriad of highly efficient copper catalyzed 
asymmetric conjugate additions30 of organozinc,26,31,32 aluminum,33 and magnesium 
reagents are available.34-36 
 
Scheme 5: Pathways for the addition of CuH to unsaturated ketones 
Recently, it was shown in related Cu catalyzed asymmetric conjugate reduction 
reactions, that the preference for 1,4-reduction (Scheme 5, Path A) could be 
changed to 1,2-reduction (Path B) by careful tuning of the properties of both 
catalyst and substrate.37-39 Here we show that the overwhelming 1,4-selectivity of 
copper(I) based chiral catalysts in the addition of organometallic reagents to Į,ȕ-
unsaturated ketones can be shifted completely towards the 1,2-product, thereby 
providing access to chiral secondary and tertiary allylic alcohols with high 
enantioselectivities. This paradigm shift allows the use of readily available, 
inexpensive Grignard reagents in the 1,2-addition to ketones without additional 
Lewis acid activation and with high asymmetric induction. 
We show that the Į-substituent and the presence of a double bond in the substrate 
play a central role in obtaining high regio- and enantioselectivity. Notably, with the 
presented methodology we can access both Į-substituted and nonsubstitued allylic 
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4.2 Results and Discussion 
4.2.1 The catalyst system 
The first step in our study was to identify the influence of the structure of the ligand 
and the substrate on the preference for 1,2- over 1,4-addition (Table 1). In addition 
to the formation of the desired 1,2-product 3, the Grignard reagent can enolise the 
substrate 1, form via ȕ-hydride transfer the corresponding secondary alcohol 5, or 
lead to the 1,4-product 4 via conjugate addition. Literature precedence shows that 
the ligand as well as the substitution pattern of the substrate plays a decisive role 
in the preference for these pathways.37,40 Therefore, both substrate 1a and Į-Me-
substituted substrate 1b were studied in the copper catalyzed addition of 
ethylmagnesium bromide with a range of chiral ligands. In the sole presence of 5 
mol% of a copper (I) salt, the reaction with both substrates proceeded with 
complete lack of chemoselectivity providing a mixture of products (Table 1, entries 
1 and 2). Performing the reaction with 1a using Cu/L1 led to a mixture of 1,2 and 
1,4-product. Despite the low regioselectivity, we were intrigued to find 
stereoinduction in the product 3aa (Table 1, entry 3). Encouraged by this result, 
substrate 1b was studied, considering the trend observed in Cu catalyzed 
reduction reactions where the Į-substitution was found to be crucial for 1,2-
selectivity.38 We were pleased to find that in the case of 1b, the reaction proceeded 
with excellent 1,2-regioselectivity and an ee of 40% for product 3ba (Table 1, entry 
4) A ligand screening (see also supplementary information) was carried out with 
selected examples presented in Table 1 (entries 4-8). It is clear that both in terms 
of 1,2-selectivity and stereoinduction, ligand L1 is remarkably effective compared 
to other members of the ferrocenyl ligand family41 L2, L3 as well as to biaryl-based 
chiral ligands L4, and L5. The catalyst precursor CuBr•SMe2 was compared to 
other commonly applied Cu salts (Table 1, entries 4, 9-13). Whilst CuCl, CuI, and 
Cu-thiophene-2-carboxylate provided the 1,2-addition product with some 
enantioselectivity, Cu(OAc)2 and [(CH3CN)4Cu]PF6 provided racemic mixtures only.  
The influence of the solvent on the selectivity of the 1,2-addition was studied with 
the CuBr•SMe2/L1 catalyst. This revealed that ethereal solvents were superior both 
in terms of regio- and stereoselectivity of the reaction. Whereas Et2O furnished 3ba 
with good chemoselectivity, the sterically more bulky ethers tBuOMe and (iPr)2O 
provided the best regio- and enantioselectivities (Table 1, entries 4, 14-15). Other 
solvents such as THF, toluene, and, surprisingly, DCM led to almost racemic 
product (entries 16-18). tBuOMe was the solvent of choice for further studies. 
Importantly, with branched-Grignard reagents such as iBuMgBr a dramatic 





observed (Table 1, entries 3, 4 and 19, 20). A small gain in chemo- and 
enantioselectivity was obtained by switching from direct to slow addition of the 
Grignard reagent (Table 1, entry 21). With optimized conditions in hand (Table 1, 
entries 20, 21), the scope of this new reaction was explored. 
 
Table 1: Optimization of the 1,2-addition of Grignard reagents to Į,ȕ-unsaturated 
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Entrya  1     CuX Ligand R'MgBr Solvent 3:4:5 
(%)b 
3, ee (%)c 
1 1a CuBr·SMe2 - 2a tBuOMe 21:79:0 - 
2 1b CuBr·SMe2 - 2a tBuOMe 25:21:9:
45e 
- 
3 1a CuBr·SMe2 L1 2a tBuOMe 16:84:0 3aa, 14 
4 1b CuBr·SMe2 L1 2a tBuOMe 97:2:1 3ba, 40 
5 1b CuBr·SMe2 L2 2a tBuOMe 95:2:3 3ba, 4 
6 1b CuBr·SMe2 L3 2a tBuOMe 89:7:4 3ba, 4 
7 1b CuBr·SMe2 L4 2a tBuOMe 82:15:3 3ba, rac 
8 1b CuBr·SMe2 L5 2a tBuOMe 84:13:3 3ba, rac 
9 1b CuCl L1 2a tBuOMe 96:2:2 3ba, 28 
10 1b CuI L1 2a tBuOMe 94:2:4 3ba, 26 
11 1b CuTC L1 2a tBuOMe 92:3:5 3ba, 18 







L1 2a tBuOMe 78:5:17 3ba, rac 
14 1b CuBr·SMe2 L1 2a Et2O 94:2:4 3ba, 18 
15 1b CuBr·SMe2 L1 2a (iPr)2O 95:3:2 3ba, 38 
16 1b CuBr·SMe2 L1 2a THF 90:3:7 3ba, 2 
17 1b CuBr·SMe2 L1 2a DCM 40:1:59 3ba, 6 
18 1b CuBr·SMe2 L1 2a Toluene 85:4:11 3ba, 6 
19 1a CuBr·SMe2 L1 2b tBuOMe 51:0:49 3ab, 32 
4ab, 30 
20 1b CuBr·SMe2 L1 2b tBuOMe 96:2:2 3bb, 82 
21d 1b CuBr·SMe2 L1 2b tBuOMe 97:1:2 3bb, 84 
a Conditions: concentration 0.15 M, 1.3 eq R’MgBr (prepared in Et2O), 15 min addition time. b Ratio of 
3:4:5 was determined by GC analysis. c Determined by HPLC analysis. d Grignard reagent was added to 
the reaction mixture over 3 h. e ‘45’ refers to unreacted substrate 1b. f CuTC refers to Cu-thiophene-2-
carboxylate. 
4.2.2 Addition to Į-substituted Į,ȕ-unsaturated ketones 
A broad range of Į-substituted Į,ȕ-unsaturated ketones was synthesized and 
investigated in the CuBr•SMe2/L1 catalyzed 1,2-addition reaction (Table 2). As 
mentioned earlier, branched Grignard reagents provided higher stereoinduction 
than linear chain reagents (Table 2, entry 1). Following this trend, the addition of 
(2-ethylbutyl)magnesium bromide 2c to enone substrate 1b proceeded with high 
selectivity affording the product with an ee of 92% and 95% yield (entry 2). 
Racemic (2-ethyl)hexylmagnesium bromide 2d proved equally effective, with no 
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negative effect of the racemic nature of the Grignard reagent on the newly formed 
stereocenter (Table 2, entry 3). Similarly, Grignard reagents bearing a carbocycle 
afforded the 1,2-addition product in high yield and enantioselectivity (Table 2, entry 
4). A diverse range of Į and Į' substituted Į,ȕ-unsaturated ketones underwent 1,2-
addition with high yields and selectivities (Table 2, entries 5-11). In particular, the 
presence of a phenyl group at the Į' position of the substrate led to good 
enantioselectivities also with linear Grignard reagents such as EtMgBr, and 
Ph(CH2)2MgBr (Table 2, entries 5 and 6). A phenyl substituent at the Į-position led 
to a slight decrease in selectivity (Table 2, entry 8). Use of the less reactive 
MeMgBr resulted in complete recovery of starting material. 
With substrate 1g we were able to obtain highly branched tertiary alcohol 3gc with 
an excellent yield and enantiomeric excess of 96% (Table 2, entry 11). Due to their 
lower inherent reactivity, enones 1h, and 1i were recovered unchanged at –78 oC. 
Increasing the reaction temperature to –60 oC furnished the 1,2-addition products 
in high yields albeit with lower enantioselectivities (entries 12 and 13).  
 
Table 2 Scope of the CuBr•SMe2/L1 catalyzed 1,2-addition of Grignard reagents to Į-





Substrateb,g R"MgBr 3:4:5 
(%)c 
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a Conditions: 1.3 eq R’’MgBr in Et2O was added over 15 min-3 h to a 0.15 M solution of substrate in 
tBuOMe. b Starting materials were prepared according to literature procedures. c Ratio of 3:4:5 was 
determined by GC analysis. d (+) and (–) are signs of optical rotation. e Determined by HPLC analysis f 
Referring to the isolated yields of product 3. g Using Z-1f as substrate led to a mixture of products and 
isomerization of the substrate. h Ligand ent-L1 was used. i Diastereomeric ratio 1:1. j Reaction was 
performed at –60 0C. 
 
4.2.3 Addition to Į-bromo substituted Į,ȕ-unsaturated ketones 
In order to access tertiary alcohols without a substituent at the Į-position also, we 
turned our attention to Į-brominated enones (Table 3). After 1,2-addition, the 
products can be readily debrominated thereby providing a formal 1,2-addition to Į-
H-substituted enones (Table 3). This strategy is reminiscent to the one developed 
by Corey et al. in the total synthesis of Aspidophytine, in which Į-bromo 
substitution was employed to increase the enantioselectivity in CBS reductions.42 
1,2-Addition of Grignard reagents to 1j proceeded readily to give the corresponding 
tertiary alcohols in excellent yields and high enantioselectivities (Table 3, entries 1 
and 2). Notably, no magnesium-bromide exchange occurred under the reaction 
conditions.  
An excellent enantioselectivity (ee 98%) and high yield were obtained, also when 
the reaction was scaled up to 3 mmol (Table 2, entry 3). Addition of a Grignard 
reagent bearing a cyclobutyl moiety furnished the product 3jh with an ee of 82% 
and a yield of 96% (Table 2, entry 4). Butenyl- and phenylethylmagnesium bromide 
2f and 2j were also employed successfully, installing a convenient handle for 
further functionalization (Table 2, entry 5, 6). As expected, an increase in steric 
hindrance of the Grignard reagent as in case of 2e led to 1,2-addition product with 
very high yield and ee (94%, Table 2, entry 7). A slight drop in enantioselectivity 
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was noticed, as observed previously, when the reactions were performed at higher 
temperature (–60 oC, Table 3, entries 7 and 8). Substituents at the aromatic moiety 
also furnished 1,2-addition products in very good selectivities (Table 3, entries 10 
and 11), and it is worth mentioning that this catalytic system also tolerates aliphatic 
substrates providing high yield and enantiomeric excess up to 94% (Table 3, 
entries 12 and 13).  
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a Conditions: 1.3 eq RMgBr (prepared in Et2O and diluted with tBuOMe) was added over 15 
min-3 h to a 0.15 M solution of substrate in tBuOMe. b Starting materials were prepared 
according to literature procedures. c Ratio of 3:4:5 was determined by GC analysis. d (+) and 
(–) are signs of optical rotation.e Determined by HPLC analysis. f Refering to the isolated 
yields of product 3 gReaction was performed on 3 mmol of 1j). h Ligand ent-L1 was used. i 
Reaction was performed at –60 0C. 
Finally, debromination was performed for 1,2-addition product 3jb (Scheme 6) 
affording the corresponding product 6 in 92% yield and with retention of ee (96%). 
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Scheme 6: Debromination of 1,2-addition product 3jb 
 
4.3 Application of the methodology  
The usefulness of the current methodology is demonstrated by the subsequent 
conversion of 3jc into a highly functionalized building block with a quaternary 
stereocenter. Exposure of 3jc to phenylacetylene under Sonogashira conditions 
resulted in coupling product 7 in excellent yield (92%) and with retention of ee 
(Scheme 7). Product 7 was readily cyclized to chiral dihydrofuran 8 in 91% yield.43 
 
Scheme 7: Conversion of 3jc into a dihydrofuran derivative 
 
4.4 Mechanistic considerations   
From a mechanistic point of view, the observed preference for 1,2-addition brought 
about by copper catalysts well-known as promoters for 1,4-addition, is intriguing.44-
46 To get more insight into the origin of such a behavior we have investigated the 
role of the Į-substituent, the importance of the double bond, as well as its 
geometry in the regio- and enantioselectivity of the reaction. To obtain high regio- 
and enantioselectivity as well as full conversion, the carbonyl function and the E-





corresponding double bond isomer Z-9 was applied as substrate (Table 4), partial 
isomerization of the starting material was observed together with a dramatic drop in 
the total selectivity of the reaction. Importantly, Z-E isomerization occurs only when 
both Grignard reagent and CuBr•SMe2/L1 are present in the reaction medium. 
 
Table 4  Z,E –isomerization upon the 1,2-addition of EtMgBr to Z-9 
 
Entrya Catalyst 10: 11 : 12 : Z-9 : E-9 (%)b 
1 CuBr•SMe2 /L1 0:62:5:24: 9 
2c CuBr•SMe2 /L1 0:0:0:100:0 
3 - 0:43:19:38:0 
a Conditions: 0.15 M in tBuOMe, 1.3 eq EtMgBr, 15 min addition time and 8 h reaction time. b Ratio was 
determined by GC analysis. cReaction performed without Grignard reagent. 
Another major requirement to persuade the catalyst to deliver the nucleophile at 
the carbonyl function with high regio and enantioselectivities is the presence of an 
Į-substituent (Me, Ph or Br) in the substrate (Table 2 and Table 3). In this way, the 
competitive conjugate addition reaction apparently is slowed down.44 For Cu-
catalyzed 1,2-reductions of enones, the same requirement was observed using 
biaryl-based diphosphine ligands.37 Our results, in addition to the necessity of Į-
substitution, show that the presence of an adjacent unsaturation is another 
prerequisite to obtain the desired 1,2-addition product with high regio- and 
enantioselectivity. This was further illustrated using phenylacetone 13a and methyl 
cyclohexyl ketone 13b as substrates. Both substrates, lacking a conjugated double 
bond, led to the corresponding 1,2-addition product with Grignard reagent 2c in low 
yields and no enantiodiscrimination (Scheme 8). On the other hand, the addition of 
Grignard reagent 2c to acetophenone 13c led to the corresponding 1,2-addition 
product 13cc with excellent yield (96%) and high ee (84%). This unexpected result 
nevertheless follows the general trend observed for our catalytic system, that is, it 
satisfies both requirements crucial for the reaction: adjacent unsaturation and Į-
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substitution. This promising outcome demonstrates that the novel reaction is not 
limited to Į,ȕ-unsaturated carbonyl compounds, but can be readily expanded to 
aromatic ketones. This study is described in Chapter 5. 
 
Scheme 8: Asymmetric 1,2-addition of 2c to phenylacetone 13a, methyl cyclohexyl ketone 13b 
and acetophenone 13c, catalyzed by CuBr•SMe2/L1. 
To understand the current mechanistic picture of this novel reaction it must be 
compared to the Cu(I)-catalyzed 1,4 addition of organometallic compounds.44-46 
That consists of the reversible formation of a copper-olefin ʌ-complex, followed by 
formal oxidative addition to the ȕ-carbon leading to a d8-copper(III) intermediate 
and, finally, rate-determining reductive elimination to form the enolate. Equipped 
with the experimental findings presented here, we hypothesize that in our system, 
in order to provide 1,2-selectivity, copper still has to bind reversibly to the double 
bond of the olefin, followed by reversible oxidative addition (Figure 4). The 
equilibrium constant between the ʌ- and the ı- complex will depend on the stability 
of Cu(III)-intermediate. Support for this hypothesis follows from the isomerization 
observed for the double bond isomer of the substrate Z-9. Most likely, the presence 
of an Į-substituent destabilizes and prevents the accumulation of Cu(III) species 
which in turn prevents 1,4-addition and favors accumulation of the ʌ-complex. The 
second role of the Į-substituent is to provide additional steric hindrance to 
discriminate between the prochiral faces of the carbonyl function. By itself, 
formation of the ʌ-complex increases the electrophilic character of the carbonyl 
moiety. Finally, the role of Mg2+ is likely the activation of the enone via coordination 
to the oxygen and association with the Cu-complex through the bridging halogen. 
These hypotheses are supported by the importance of the nature of the halide 







Figure 4: Proposed mechanistic pathway for the 1,2 addition of Grignard reagents to Į,ȕ-
unsaturated ketones catalyzed by CuBr•SMe2/L1. 
Chiral Lewis acid activation of the carbonyl group, chiral Lewis base activation of 
the carbon-metal bond of the nucleophile, or a combination of both strategies are 
commonly used to address the low reactivity of ketones and poor 
enantiodiscrimination in catalytic asymmetric 1,2-addition reactions.12 Our findings 
point at a conceptually new strategy. To activate and to achieve pronounced 
discrimination between the prochiral faces of the ketone, the catalyst must 
coordinate to one of its substituents. This type of catalyst coordination in principle 
provides increased enantiodiscrimination due to the larger steric and electronic 
differences between the two substituents of the carbonyl moiety. In our case, the 
adjacent double bond in the substrate serves as the site for catalyst coordination. 
The approach presented here in some way resembles the use of Į-ketoesters in 
aldol reactions,47 where the ester moiety provides a site for coordination to the 
catalyst, thereby enhancing the enantiodiscrimination. 
 
4.5 Summary and concluding remarks 
In this chapter, we demonstrate that the inherent preference of Cu(I)-based 
catalysts for 1,4-addition of organometallic reagents can be fully shifted to 1,2-
addition by subtle interplay of the steric and electronic properties of all reaction 
components. This discovery led to the first catalytic asymmetric addition of 
Grignard reagents to carbonyl compounds, with excellent regioselectivity and 
enantioselectivities up to 98% ee. The high tolerance of this catalytic methodology 
to Į-alkyl, phenyl and bromo substituted substrates gives access to a broad range 
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of highly valuable tertiary allylic alcohols. The versatility of the Į-bromo tertiary 
alcohols is highlighted in their transformation to an enantiopure dihydrofuran 
containing a quaternary stereocenter. The current results indicate that this copper 
catalyzed 1,2-addition proceeds via initial d-ʌ complex formation and that the Į-
substitution is crucial in order to achieve excellent 1,2-selectivity. Combined, these 
results start an entirely new role of Cu(I) based catalysts in asymmetric synthesis.  
 
4.6 Experimental section 
General 
Flash chromatography: Merck silica gel type 9385 230-400 mesh, TLC: Merck 
silica gel 60, 0.25 mm. Components were visualized by UV and Seebach’s reagent, 
a mixture of phosphomolybdic acid (25 g), cerium (IV) sulfate (7.5 g), H2O (500 mL) 
and H2SO4 (25 mL) or potassium permanganate staining. Progress and conversion 
of the reaction were determined by GC-MS (GC, HP6890: MS HP5973) with an 
HP1 or HP5 column (Agilent Technologies, Palo Alto, CA).  High resolution mass 
spectra (HRMS) were recorded on a AEI-MS-902 and FTMS orbitrap (Thermo 
Fisher Scientific) mass spectrometer. 1H- and 13C-NMR were recorded on a Varian 
AMX400 (400 and 100.59 MHz, respectively) or a Varian Gemini 200, using CDCl3 
as solvent. Chemical shift values are reported in ppm with the solvent resonance 
as the internal standard (CHCl3: G 7.26 for 1H, G 77.0 for 13C). Data are reported as 
follows: chemical shifts, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, 
br = broad, m = multiplet), coupling constants (Hz), and integration. Carbon 
assignments are based on APT 13C-NMR experiments. Optical rotations were 
measured on a Schmidt + Haensch polarimeter (Polartronic MH8) with a 10 cm cell 
(c given in g/100 mL). Enantiomeric excesses were determined by HPLC analysis 
using a Shimadzu LC-10ADVP HPLC equipped with a Shimadzu SPD-M10AVP 
diode array detector or by capillary GC analysis (HP 6890, CP-Chiralsil-Dex-CB 
column (25 m x 0.25 mm) or Chiraldex B-PM (30 m x 0.25 mm x 0.25 ȝm)) using a 
flame ionization detector. 
All reactions were carried out under a nitrogen atmosphere using oven dried 
glassware and using standard Schlenk techniques. tBuOMe and dichloromethane 
were dried and distilled from calcium hydride; toluene, THF and n-hexane were 
dried and distilled from sodium. All copper salts were purchased from Aldrich, and 
used without further purification. Starting materials 1b-1g and 1j were prepared 
following literature procedures.38,48 Grignard reagents were purchased from Aldrich 
(iBuMgBr (2 M in Et2O), EtMgBr (3 M in Et2O), n-PentylMgBr (2 M in Et2O). Ligands 
L1-11 were purchased from Aldrich. Phosphoramidite ligand L12 was prepared as 
reported in the literature.49 Racemic products were synthesized by reaction of the 
Į,ȕ-unsaturated ketones (1) and the corresponding Grignard reagent at rt in Et2O. 
All Grignard reagents were prepared from the corresponding alkyl bromides and 






General procedures for the copper-catalyzed 1,2-addition of Grignard 
reagents. 
Procedure A: addition to Į-substituted Į,ȕ-unsaturated ketones 1a-h 
A Schlenk tube equipped with septum and stirring bar was charged with 
CuBr•SMe2 (0.015 mmol, 3.08 mg, 5 mol%) and ligand L1 (0.018 mmol, 6 mol%). 
Dry tBuOMe (3 mL) was added and the solution was stirred under nitrogen at room 
temperature for 15 min. Then, Į,ȕ-unsaturated ketone 1 (0.3 mmol in 1 mL 
tBuOMe) was added and the resulting solution was cooled to –78 °C. The 
corresponding Grignard reagent 2 (0.36 mmol, 1.2 eq, in Et2O) was diluted with 
tBuOMe (combined volume of 1 mL) under nitrogen and added to the reaction 
mixture over 15 min. Once the addition was complete, the reaction mixture was 
monitored by TLC and GCMS. The reaction was quenched by the addition of 
MeOH (1 mL) and saturated aqueous NH4Cl (2 mL) and the mixture was warmed 
to room temperature, diluted with Et2O and the layers were separated. The 
aqueous layer was extracted with Et2O (3 x 5 mL) and the combined organic layers 
were dried with anhydrous Na2SO4, filtered and the solvent was evaporated in 
vacuo. The crude product was purified by flash chromatography on silica gel using 
mixtures of n-pentane and Et2O as the eluent. Gas chromatography analysis was 
carried out to determine the 1,2-addition, 1,4-addition and 1,2-reduction ratio on a 
sample obtained after aqueous workup and extraction with Et2O, which was 
passed through a short plug of silica gel to remove copper residues. 
 
Procedure B: addition to Į-substituted Į,ȕ-unsaturated ketones 1a-h 
A Schlenk tube equipped with septum and stirring bar was charged with 
CuBr•SMe2 (0.015 mmol, 3.08 mg, 5 mol%) and ligand L1 (0.018 mmol, 6 mol%). 
Dry tBuOMe (3 mL) was added and the solution was stirred under nitrogen at room 
temperature for 15 min. Then, Į,ȕ-unsaturated ketone 1 (0.3 mmol in 1 mL 
tBuOMe) was added and the resulting solution was cooled to –78 °C. In a separate 
Schlenk, the corresponding Grignard reagent 2 (0.36 mmol, 1.2 eq) was diluted 
with tBuOMe (combined volume of 1 mL) under nitrogen and added dropwise to 
the reaction mixture over 3 hours using a syringe pump. Once the addition was 
complete, the reaction mixture was monitored by TLC and GCMS. The reaction 
was quenched by the addition of MeOH (1 mL) and saturated aqueous NH4Cl (2 
mL) and the mixture was warmed to room temperature, diluted with Et2O and the 
layers were separated. The aqueous layer was extracted with Et2O (3 x 5 mL) and 
the combined organic layers were dried with anhydrous Na2SO4, filtered and the 
solvent was evaporated in vacuo. The crude product was purified by flash 
chromatography on silica gel using mixtures of n-pentane and Et2O as the eluent. 
 
Procedure C: addition to Į-substituted Į,ȕ-unsaturated ketones 1a-h 
A Schlenk tube equipped with septum and stirring bar was charged with 
CuBr•SMe2 (0.015 mmol, 3.08 mg, 5 mol%) and ligand L1 (0.018 mmol, 6 mol%). 
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Dry tBuOMe (3 mL) was added and the solution was stirred under nitrogen at room 
temperature for 15 min. Then, Į,ȕ-unsaturated ketone 1 (0.3 mmol in 1 mL 
tBuOMe) was added and the resulting solution was cooled to –60 °C. The 
corresponding Grignard reagent 2 (0.36 mmol, 1.2 eq, in Et2O) was diluted with 
tBuOMe (combined volume of 1 mL) under nitrogen and added to the reaction 
mixture over 15 min. Once the addition was complete, the reaction mixture was 
monitored by TLC and GCMS. The reaction was quenched by the addition of 
MeOH (1 mL) and saturated aqueous NH4Cl (2 mL) and the mixture was warmed 
to room temperature, diluted with Et2O and the layers were separated. The 
aqueous layer was extracted with Et2O (3 x 5 mL) and the combined organic layers 
were dried with anhydrous Na2SO4, filtered and the solvent was evaporated in 
vacuo. The crude product was purified by flash chromatography on silica gel using 
mixtures of n-pentane and Et2O as the eluent. 
 
(+)-(E)-2,3-Dimethyl-1-phenylpent-1-en-3-ol (3ba): 
 Using method A: Reaction was performed with ligand ent-L1 and 
EtMgBr. Colorless oil obtained as a 97:2:1 mixture of 3ba, 4ba, and 5ba after 
column chromatography (SiO2, n-pentane:Et2O 90:10), 3ba [95% yield, 40% ee)]. 
1H NMR (400 MHz, CDCl3) į 7.39 – 7.29 (m, 2H), 7.26 – 7.17 (m, 3H), 6.65 (s, 1H), 
1.83 (s, 3H), 1.70 (m, 2H), 1.48 (s, 1H), 1.40 (s, 3H), 0.88 (t, J = 7.4, 3H). 13C NMR 
(101 MHz, CDCl3) į 143.06, 138.61, 129.03, 127.99, 126.07, 123.67, 76.21, 33.02, 
27.39, 14.59, 8.10. [Į]D20 =  +2.2 (c = 0.8, CHCl3). HRMS (ESI+, m/z): calcd for 
C13H18O-OH [M-OH]+: 173.1331; found: 173.1337. Enantiomeric excess was 
determined by chiral HPLC analysis, Chiralcel AD-H column, n-heptane/i-PrOH 
98:2, 40 °C, detection at 240 nm, retention times (min): 23.8(major) and 
24.9(minor). The absolute configuration of this compound is assumed to be (R), 
analogous to the other products. 
 
(+)-(E)-2,3,5-Trimethyl-1-phenylhex-1-en-3-ol (3bb): 
Using method B: Reaction was performed with ligand ent-L1 and 
iBuMgBr. Colorless oil obtained as a 97:1:2 mixture of 3bb, 4bb, and 5bb after 
column chromatography (SiO2, n-pentane:Et2O 90:10), 3bb [93% yield, 84% ee]. 
The same above reaction performed by using method A: Colorless oil obtained as 
a 96:2:2 mixture of 3bb, 4bb, and 5bb after column chromatography (SiO2, n-
pentane:Et2O 90:10), 3bb [92% yield, 82% ee].1H NMR (400 MHz, CDCl3) į 7.33 
(t, J = 7.6, 2H), 7.26 – 7.17 (m, 3H), 6.70 (s, 1H), 1.83 (s, 3H), 1.7 (s, 1H), 1.59 – 





6.6, 3H). 13C NMR (101 MHz, CDCl3) į 143.54, 138.55, 129.00, 128.00, 126.05, 
123.16, 76.56, 48.89, 28.99, 24.42, 24.35, 15.07. [Į]D20 =  +8.0 (c = 0.5, CHCl3).  
HRMS (ESI+, m/z): calcd for C15H22O-OH [M-OH]+: 201.1644; found: 201.1649. 
Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel AD-H 
column, n-heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, retention times (min): 
16.7(major) and 20.3(minor). The absolute configuration of this compound is 




Using method A: Reaction was performed with ligand L1 and (2-
ethylbutyl)magnesium bromide. Colorless oil obtained as a 97:1:2 mixture of 3bc, 
4bc, and 5bc after column chromatography (SiO2, n-pentane:Et2O 90:10), 3bc 
[95% yield, 92% ee]. 1H NMR (400 MHz, CDCl3) į 7.33 (t, J = 7.5, 2H), 7.26 – 7.17 
(m, 3H), 6.68 (s, 1H), 1.83 (s, 3H), 1.70 – 1.51 (m, 2H), 1.48 (s, 3H), 1.32 (m, 5H), 
0.82 (t, J = 7.2, 3H), 0.71 (t, J = 7.3, 3H). 13C NMR (101 MHz, CDCl3) į 143.55, 
138.60, 129.00, 128.01, 126.03, 123.29, 76.53, 43.54, 36.29, 28.85, 26.46, 15.09, 
10.84. [Į]D20 =  –7.0 (c = 0.8, CHCl3).  HRMS (ESI+, m/z): calcd for C17H26O-OH 
[M-OH]+: 229.1957; found: 229.1963. Enantiomeric excess was determined by 
chiral HPLC analysis, Chiralcel AD-H column, n-heptane/i-PrOH 98:2, 40 °C, 
detection at 240 nm, retention times (min): 15.8(minor) and 16.5(major). The 




Using method B: Reaction was performed with ligand ent-L1 and 
(2-ethylhexyl)magnesium bromide. Colorless oil obtained as a 99:0:1 mixture of 
3bd, 4bd, and 5bd after column chromatography (SiO2, n-pentane:Et2O 90:10), 
3bd [96% yield, 1:1 dr, 92% ee]. 1H NMR (400 MHz, CDCl3) į 7.46 – 7.29 (m, 3H), 
7.22 (dd, J = 18.3, 7.4, 2H), 6.68 (s, 1H), 2.47 (s, 1H), 1.83 (s, 3H), 1.59 (m, 3H), 
1.47 – 1.36 (m, 6H), 1.35 – 1.16 (m, 5H), 0.86 (m, 6H). 13C NMR (101 MHz, CDCl3) 
į 143.58, 129.67, 129.00, 128.44, 128.00, 126.02, 123.29, 76.58, 76.54, 44.00, 
34.85, 34.01, 33.92, 28.91, 28.88, 26.95, 23.09, 15.10, 14.13, 10.77. [Į]D20 =  +2.4 
(c = 1.3, CHCl3).  HRMS (ESI+, m/z): calcd for C19H30O-OH [M-OH]+: 257.2270; 
found: 257.2264. Enantiomeric excess was determined by chiral HPLC analysis, 
Chiralcel AD-H column, n-heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, 
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retention times (min): 11.8(major) and 12.7(minor). The absolute configuration of 




Using method A: Reaction was performed with ligand ent-L1 and 
(cyclohexylmethyl)magnesium bromide. Colorless oil obtained as a 99:1:0 mixture 
of 3be, 4be, and 5be after column chromatography (SiO2, n-pentane:Et2O 90:10), 
3be [95% yield, 88% ee]. 1H NMR (400 MHz, CDCl3) į 7.39 – 7.31 (m, 2H), 7.26 – 
7.18 (m, 3H), 6.70 (s, 1H), 1.83 (s, 3H), 1.77 – 1.50 (m, 8H), 1.46 – 1.38 (s, 3H), 
1.34 – 1.09 (m, 3H), 1.08 – 0.89 (m, 2H). 13C NMR (101 MHz, CDCl3) į 143.62, 
138.65, 129.01, 128.03, 126.04, 123.16, 76.55, 47.72, 35.08, 33.86, 28.94, 26.47, 
26.32, 15.12. [Į]D20 =  +1.2 (c = 2.5, CHCl3).  HRMS (ESI+, m/z): calcd for C18H26O-
OH [M-OH]+: 241.1957; found: 241.1952. Enantiomeric excess was determined by 
chiral HPLC analysis, Chiralcel AD-H column, n-heptane/i-PrOH 99:1, 40 °C, 
detection at 240 nm, retention times (min): 22.4(minor) and 23.2(major). The 




 Using method A: Reaction was performed with ligand L1 and 
EtMgBr. Colorless oil obtained as a 95:3:2 mixture of 3ca, 4ca, and 5ca after 
column chromatography (SiO2, n-pentane:Et2O 90:10), 3ca [94% yield, 84% ee].1H 
NMR (400 MHz, CDCl3) į 7.56 – 7.46 (m, 2H), 7.41 – 7.26 (m, 7H), 7.26 – 7.19 (m, 
1H), 6.89 (s, 1H), 2.31 – 2.07 (m, 2H), 1.82 (s, 1H), 1.66 (s, 3H), 0.94 (t, J = 7.3, 
3H). 13C NMR (101 MHz, CDCl3) į 145.07, 141.72, 138.25, 129.09, 128.12, 
128.05, 126.92, 126.28, 125.89, 124.76, 79.77, 31.38, 15.01, 7.91. [Į]D20 =  –59.1 
(c = 0.9, CHCl3).  HRMS (ESI+, m/z): calcd for C18H20O-OH [M-OH]+: 235.1487; 
found: 235.1481. Enantiomeric excess was determined by chiral HPLC analysis, 
Chiralcel AD-H column, n-heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, 











Using method C: Reaction was performed with ligand L1 and 
phenethylmagnesium bromide. Colorless oil obtained as a 86:12:2 mixture of 3cf, 
4cf, and 5cf after column chromatography (SiO2, n-pentane:Et2O 90:10), 3cf [83% 
yield, 62% ee]. 1H NMR (400 MHz, CDCl3) į 7.60 – 7.48 (m, 2H), 7.43 – 7.27 (m, 
9H), 7.25 – 7.09 (m, 4H), 6.95 (s, 1H), 2.69 (m, 2H), 2.56 – 2.35 (m, 2H), 1.92 (s, 
1H), 1.71 (d, J = 1.1, 3H). 13C NMR (101 MHz, CDCl3) į 144.97, 142.54, 141.55, 
138.02, 129.11, 128.46, 128.28, 128.10, 127.13, 126.40, 125.86, 124.96, 79.56, 
41.11, 30.24, 15.09. [Į]D20 =  –26 (c = 0.5, CHCl3).  HRMS (ESI+, m/z): calcd for 
C24H24O-OH [M-OH]+: 311.1807; found: 311.1801. Enantiomeric excess was 
determined by chiral HPLC analysis, Chiralcel AD-H column, n-heptane/i-PrOH 
98:2, 40 °C, detection at 240 nm, retention times (min): 53.2(minor) and 
55.3(major). The absolute configuration of this compound is assumed to be (S), 




 Using method A: Reaction was performed with ligand L1 and (2-
ethylbutyl)magnesium bromide. Colorless oil obtained as a 98:1:1 mixture of 3dc, 
4dc, and 5dc after column chromatography (SiO2, n-pentane:Et2O 95:05), 3dc 
[95% yield, 76% ee]. 1H NMR (400 MHz, CDCl3) į 7.40 – 7.29 (m, 2H), 7.26 – 7.17 
(m, 3H), 6.68 (s, 1H), 1.75 (s, 3H), 1.65 – 1.53 (m, 4H), 1.47 – 1.41 (m, 1H), 1.29 
(d, J = 3.8, 2H), 1.25 (t, J = 6.5, 2H), 0.90 – 0.77 (m, 9H). 13C NMR (101 MHz, 
CDCl3) į 141.30, 138.73, 128.99, 127.95, 125.93, 124.85, 78.88, 42.77, 35.86, 
33.19, 26.42, 15.27, 10.60, 7.31. [Į]D20 =  –13.3 (c = 0.3, CHCl3).  HRMS (ESI+, 
m/z): calcd for C18H28O-OH [M-OH]+: 243.2113; found: 243.2109. Enantiomeric 
excess was determined by chiral HPLC analysis, Chiralcel AD-H column, n-
heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, retention times (min): 
13.7(minor) and 14.4(major). The absolute configuration of this compound is 
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(+)-(E)-3-Isopropyl-2-methyl-1-phenylocta-1,7-dien-3-ol (3eg): 
Using method A: Reaction was performed with ligand L1 and 
pent-4-en-1-ylmagnesium bromide. Colorless oil obtained as a 98:0:2 mixture of 
3eg, 4eg, and 5eg after column chromatography (SiO2, n-pentane:Et2O 90:10), 
3eg [95% yield, 66% ee]. 1H NMR (400 MHz, CDCl3) į 7.40 – 7.29 (m, 2H), 7.26 – 
7.16 (m, 3H), 6.65 (s, 1H), 5.81 (m, 1H), 5.15 – 4.86 (m, 2H), 2.18 – 1.90 (m, 3H), 
1.75 (s, 3H), 1.72 – 1.57 (m, 2H), 1.56 – 1.41 (m, 1H), 1.35 (s, 1H), 1.32 – 1.16 (m, 
1H), 1.02 (d, J = 6.7, 3H), 0.86 (d, J = 9.8, 3H). 13C NMR (101 MHz, CDCl3) į 
141.24, 138.81, 138.63, 129.03, 128.01, 125.99, 124.79, 114.60, 79.93, 36.25, 
34.13, 23.14, 17.11, 16.21, 15.09. [Į]D20 =  +24.5 (c = 3.4, CHCl3).  HRMS (ESI+, 
m/z): calcd for C18H26O-OH [M-OH]+: 241.1957; found: 241.1956. Enantiomeric 
excess was determined by chiral HPLC analysis, Chiralcel AD-H column, n-
heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, retention times (min): 12.7 
(major) and 41.6 (minor). The absolute configuration of this compound is assumed 
to be (R), analogous to the other products. 
 
(ņ)-(E)-3,5-Dimethyl-1,2-diphenylhex-1-en-3-ol (3fb): 
Using method C: Reaction was performed with ligand L1 and 
iBuMgBr. Colorless oil obtained as a 84:12:4 mixture of 3fb, 4fb, and 5fb after 
column chromatography (SiO2, n-pentane:Et2O 90:10), 3fb [81% yield, 68% ee]. 1H 
NMR (400 MHz, CDCl3) į 7.43 – 7.28 (m, 3H), 7.15 (dd, J = 7.8, 1.6, 2H), 7.05 (dd, 
J = 5.2, 2.0, 3H), 6.87 (s, 1H), 6.81 (dd, J = 7.2, 2.5, 2H), 1.97 (m, 1H), 1.64 – 1.60 
(dd, J = 14.5, 5.0, 2H), 1.50 (s, 1H), 1.40 (s, 3H), 1.00 (2d, J = 6.7, 6H). 13C NMR 
(101 MHz, CDCl3) į 148.72, 139.28, 137.00, 129.83, 129.16, 128.49, 127.79, 
127.10, 126.42, 125.47, 76.71, 49.18, 29.11, 24.74, 24.52. [Į]D20 =  –19.1 (c = 0.7, 
CHCl3). HRMS (ESI+, m/z): calcd for C20H24O-OH [M-OH]+: 263.1801; found: 
263.1794. Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel 
AD-H column, n-heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, retention times 
(min): 22.4 (minor) and 24.0 (major). The absolute configuration of this compound 











 Using method C: Reaction was performed with ligand L1 and 
(cyclobutylmethyl)magnesium bromide. Colorless oil obtained as a 92:5:3 mixture 
of 3ch, 4ch, and 5ch after column chromatography (SiO2, n-pentane:Et2O 90:10), 
3ch [87% yield, 76% ee]. 1H NMR (400 MHz, CDCl3) į 7.47 (dd, J = 13.0, 11.6, 
2H), 7.38 – 7.28 (m, 6H), 7.25 – 7.18 (m, 2H), 6.86 (s, 1H), 2.46 (d, J = 8.6, 1H), 
2.26 (m, 3H), 2.15 – 1.98 (m, 1H), 1.82 (s, 3H), 1.64 (t, J = 8.1, 3H), 1.55 (s, 1H). 
13C NMR (101 MHz, CDCl3) į 145.34, 142.17, 138.19, 129.52, 129.07, 128.55, 
128.05, 128.04, 126.83, 126.26, 125.80, 124.29, 79.91, 45.96, 31.97, 30.02, 19.61, 
15.12. [Į]D20 =  –32.1 (c = 0.9, CHCl3).  HRMS (ESI+, m/z): calcd for C21H24O-OH 
[M-OH]+: 275.1801; found: 275.1796. Enantiomeric excess was determined by 
chiral HPLC analysis, Chiralcel AD-H column, n-heptane/i-PrOH 98:2, 40 °C, 
detection at 240 nm, retention times (min): 26.6 (major) and 27.8 (minor). The 





 Using method C: Reaction was performed with ligand ent-L1 and 
(2-ethylbutyl)magnesium bromide. Colorless oil obtained as a 96:1:3 mixture of 
3gc, 4gc, and 5gc after column chromatography (SiO2, n-pentane:Et2O 97:03), 
3gc [92% yield,  96% ee]. 1H NMR (400 MHz, CDCl3) į 7.45 – 7.29 (m, 3H), 7.26 – 
7.17 (m, 2H), 6.73 (s, 1H), 2.10 – 2.01 (s, 1H), 1.77 (s, 3H), 1.74 – 1.55 (m, 3H), 
1.54 – 1.21 (m, 7H), 1.07 – 0.92 (m, 6H), 0.89 – 0.76 (m, 6H). 13C NMR (101 MHz, 
CDCl3) į 141.75, 138.79, 129.66, 128.97, 128.40, 128.02, 125.95, 124.41, 79.39, 
49.33, 43.93, 35.64, 26.49, 24.57, 24.04, 15.78, 10.83. [Į]D20 =  +1.9 (c = 1.3, 
CHCl3). HRMS (ESI+, m/z): calcd for C20H32O-OH [M-OH]+: 271.2426; found: 
271.2420. Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel 
AD-H column, n-heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, retention times 
(min): 10.3 (major) and 10.9 (minor). The absolute configuration of this compound 
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(+)-(R)-2-(Cyclohex-1-en-1-yl)butan-2-ol (3ha): 
Using method B: Reaction was performed with ligand ent-L1 and EtMgBr. 
Colorless oil obtained as a 87:12:2 mixture of 3ha, 4ha, and 5ha after column 
chromatography (SiO2, n-pentane:Et2O 90:10), 3ha [82% yield, 42% ee]. The 
spectral data were identical in all aspects to those previously reported.50,51 [Į]D20 = 
+0.6 (c = 2.9, MeOH), [lit. (51% ee): [Į]D20 = +0.7 (c = 3.0, MeOH)]. Enantiomeric 
excess was determined by chiral HPLC analysis, Chiralcel AD-H column, n-
heptane/i-PrOH 98:2, 40 °C, detection at 215 nm, retention times (min): 14.3 
(major) and 15.2 (minor).  
 
(ņ)-(E)-3,4,6-Trimethylhept-2-en-4-ol (3ib): 
Using method C: Reaction was performed with ligand L1 and iBuMgBr. 
Colorless oil obtained as a 89:8:3 mixture of 3ib, 4ib, and 5ib after column 
chromatography (SiO2, n-pentane:Et2O 90:10), 3ib [85% ,48% ee]. The spectral 
data were identical in all aspacts to those previously reported.52 [Į]D20 = –2.8 (c = 
0.5, CHCl3). Enantiomeric excess was determined by chiral HPLC analysis, 
Chiralcel AD-H column, n-heptane/i-PrOH 100:00, 40 °C, detection at 240 nm, 
retention times (min): 18.9 (minor) and 20.2 (major). The absolute configuration of 




Br Using method B: Reaction was performed with ligand L1 and 
iBuMgBr. Colorless oil obtained as a 97:1:2 mixture of 3jb, 4jb, and 5jb after 
column chromatography (SiO2, n-pentane:Et2O 90:10), 3jb [94% yield, 90% ee]. 1H 
NMR (400 MHz, CDCl3) į 7.54 (m, 2H), 7.40 – 7.26 (m, 3H), 7.24 (s, 1H), 1.99 (s, 
1H),  1.97 – 1.74 (m, 2H), 1.65 (m, 1H), 1.61 – 1.54 (s, 3H), 0.99 (2d, J = 6.7, 6H). 
13C NMR (101 MHz, CDCl3) į 136.22, 134.69, 129.02, 128.05, 127.66, 126.25, 
77.61, 49.12, 28.76, 24.49, 24.24. [Į]D20 =  +17.4 (c = 0.9, CHCl3). HRMS (ESI+, 
m/z): calcd for C14H19BrO-OH [M-OH]+: 265.0592; found: 265.0487. Enantiomeric 
excess was determined by chiral HPLC analysis, Chiralcel AD-H column, n-
heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, retention times (min): 22.0 
(minor) and 27.1 (major). The absolute configuration of this compound is assumed 







Reaction was performed with 3bb, 2 mmol in Et2O (2 mL) cooled 
to –80°C. After 15 min at that temperature, 1.2 eq of t-BuLi was added and the 
mixture was stirred for another 30 min at –80°C. The reaction was quenched with 
saturated aqueous NH4Cl (2 mL) and the mixture was warmed up to room 
temperature, diluted with Et2O and the layers were separated. The aqueous layer 
was extracted with Et2O (3 x 5 mL) and the combined organic layers were dried 
with anhydrous Na2SO4, filtered and the solvent was evaporated in vacuo. Product 
6 was obtained as a colorless oil after column chromatography (SiO2, n-
pentane:Et2O 90:10), [96% yield, 90% ee]. The physical data were identical in all 
respects to those previously reported.53 [Į]D20 = +21.5 (c = 1.1, CHCl3). 
Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel AD-H 
column, n-heptane/i-PrOH 98:02, 40 °C, detection at 240 nm, retention times (min): 
21.9(major) and 23.2(minor). 
 
(+)-(Z)-2-Bromo-5-ethyl-3-methyl-1-phenylhept-1-en-3-ol (3jc):  
HO
Br  Using method A: Reaction was performed with ligand L1 and (2-
ethylbutyl)magnesium bromide. Colourless oil obtained as a 96:2:2 mixture of 3jc, 
4jc, and 5jc after column chromatography (SiO2, n-pentane:Et2O 90:10), 3jc [94% 
yield, 96% ee]. 1H NMR (201 MHz, CDCl3) į 7.53 (d, J = 7.4, 2H), 7.35 (m, 3H), 
7.22 (s, 1H), 1.99 (s, 1H) 1.97 – 1.66 (m, 2H), 1.59 (s, 3H), 1.50 – 1.24 (m, 5H), 
0.87 (t, J = 6.6, 6H). 13C NMR (50 MHz, CDCl3) į 136.28, 134.95, 129.00, 128.06, 
127.63, 126.34, 77.58, 43.79, 36.36, 28.59, 26.46, 10.79. [Į]D20 =  +17.1 (c = 1.2, 
CHCl3). HRMS (ESI+, m/z): calcd for C16H23BrO-OH [M-OH]+: 293.0905; found: 
293.0879. Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel 
AD-H column, n-heptane/i-PrOH 99:1, 40 °C, detection at 240 nm, retention times 
(min): 25.6(minor) and 27.3(major). The absolute configuration of this compound is 
assumed to be (R), analogous to the other products. The same above reaction was 
performed by using method B on 3 mmol scale: Colorless oil obtained as a 94:2:4 
mixture of 3jc, 4jc, and 5jc after column chromatography (SiO2, n-pentane:Et2O 
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Asymmetric 1,2-addition of Grignard reagents to enones 
(+)- (Z)-3-Bromo-1-cyclobutyl-2-methyl-4-phenylbut-3-en-2-ol (3jh): 
Using method A: Reaction was performed with ligand L1 and 
(cyclobutylmethyl)magnesium bromide. Colorless oil obtained as a 98:1:1 mixture 
of 3jh, 4jh, and 5jh after column chromatography (SiO2, n-pentane:Et2O 90:10), 
3jh [96% yield, 82% ee]. 1H NMR (400 MHz, CDCl3) į 7.61 – 7.51 (m, 2H), 7.43 – 
7.26 (m, 3H), 7.15 (s, 1H), 2.48 (m, 1H), 2.19 – 1.71 (m, 8H), 1.55 (s, 3H). 13C 
NMR (101 MHz, CDCl3) į 136.18, 134.68, 129.01, 128.05, 127.67, 126.21, 77.45, 
47.79, 32.04, 29.66, 27.60, 19.49. [Į]D20 =  +13.3 (c = 0.9, CHCl3).  HRMS (ESI+, 
m/z): calcd for C15H19BrO-OH [M-OH]+: 277.0592; found: 277.0583. Enantiomeric 
excess was determined by chiral HPLC analysis, Chiralcel AD-H column, n-
heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, retention times (min): 
23.4(minor) and 28.2(major). The absolute configuration of this compound is 
assumed to be (R), analogous to the other products. 
 
(ņ)-(Z)-2-Bromo-3-methyl-1,5-diphenylpent-1-en-3-ol (3jf): 
 Using method A: Reaction was performed with ligand ent-L1 
and phenethylmagnesium bromide. Colorless oil obtained as a 97:2:1 mixture of 
3jf, 4jf, and 5jf after column chromatography (SiO2, n-pentane:Et2O 90:10), 3jf 
[94% yield, 72% ee]. 1H NMR (400 MHz, CDCl3) į 7.64 – 7.54 (m, 2H), 7.38 (dd, J 
= 10.0, 4.8, 2H), 7.35 – 7.26 (m, 4H), 7.21 (dd, J = 15.1, 7.0, 3H), 2.68 (m, 2H), 2.1 
(s, 1H), 2.14 – 1.98 (m, 2H), 1.62 (s, 3H). 13C NMR (101 MHz, CDCl3) į 141.79, 
136.01, 133.54, 129.06, 128.47, 128.41, 128.10, 127.80, 126.94, 125.94, 77.16, 
42.72, 30.39, 28.00. [Į]D20 =  –8.0 (c = 0.3, CHCl3).  HRMS (ESI+, m/z): calcd for 
C18H19BrO-OH [M-OH]+: 313.0592; found: 313.0590. Enantiomeric excess was 
determined by chiral HPLC analysis, Chiralcel AD-H column, n-heptane/i-PrOH 
98:2, 40 °C, detection at 240 nm, retention times (min): 43.8(major) and 
47.7(minor). The absolute configuration of this compound is assumed to be (S), 












 Using method B: Reaction was performed with ligand ent-L1 and 
but-3-en-1-ylmagnesium bromide. Colorless oil obtained as a 99:1:0 mixture of 3jj, 
4jj, and 5jj after column chromatography (SiO2, n-pentane:Et2O 90:10), 3jj [96% 
yield, 60% ee]. 1H NMR (400 MHz, CDCl3) į 7.55 (d, J = 7.9, 2H), 7.45 – 7.27 (m, 
3H), 7.21 (s, 1H), 5.88 (m, 1H), 5.19 – 4.83 (m, 2H), 2.21 – 2.10 (m, 3H), 2.10 – 
1.98 (m, 1H), 1.82 (m, 1H), 1.57 (s, 3H). 13C NMR (101 MHz, CDCl3) į 138.43, 
136.05, 133.71, 129.03, 128.07, 127.75, 126.75, 115.12, 77.26, 39.73, 28.43, 
27.88. [Į]D20 = –4.3 (c = 1, CHCl3). HRMS (ESI+, m/z): calcd for C14H17BrO-OH [M-
OH]+: 263.0436; found: 263.0431. Enantiomeric excess was determined by chiral 
HPLC analysis, Chiralcel AD-H column, n-heptane/i-PrOH 98:2, 40 °C, detection at 
240 nm, retention times (min): 25.9 (minor) and 29.0 (major). The absolute 




 Using method A: Reaction was performed with ligand ent-L1 and 
(cyclohexylmethyl)magnesium bromide. Colorless oil obtained as a 99:1:0 mixture 
of 3je, 4je, and 5je after column chromatography (SiO2, n-pentane:Et2O 90:10), 3je 
[96% yield, 94% ee]. The same above reaction was performed by using method C: 
Colorless oil obtained as a 96:2:2 mixture of 3je, 4je, and 5je after column 
chromatography (SiO2, n-pentane:Et2O 90:10), 3je [94% yield, 86% ee]. 1H NMR 
(400 MHz, CDCl3) į 7.54 (d, J = 7.3, 2H), 7.41 – 7.27 (m, 3H), 7.23 (s, 1H), 1.99 (s, 
1H), 1.90 – 1.74 (m, 3H), 1.74 – 1.60 (m, 4H), 1.58 (s, 3H), 1.52 – 1.39 (m, 1H), 
1.33 – 0.94 (m, 5H). 13C NMR (101 MHz, CDCl3) į 136.31, 134.89, 129.01, 128.08, 
127.64, 126.24, 77.63, 47.94, 34.88, 33.89, 28.71, 26.41, 26.25. [Į]D20 =  –12.4 (c = 
2.8, CHCl3). HRMS (ESI+, m/z): calcd for C17H23BrO-OH [M-OH]+: 305.0905; 
found: 305.0917. Enantiomeric excess was determined by chiral HPLC analysis, 
Chiralcel AD-H column, n-heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, 
retention times (min): 25.9 (major) and 26.7 (minor). The absolute configuration of 
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(+)-(Z)-2-Bromo-3-methyl-1-phenylpent-1-en-3-ol (3ja): 
Using method B: Reaction was performed with ligand L1 and 
EtMgBr. Colorless oil obtained as a 98:1:1 mixture of 3ja, 4ja, and 5ja after column 
chromatography (SiO2, n-pentane:Et2O 90:10), 3ja [96% yield, 42% ee]. 1H NMR 
(400 MHz, CDCl3) į 7.54 (d, J = 7.5, 2H), 7.33 (m, 3H), 7.18 (s, 1H), 1.86 (m, 3H), 
1.56 (s, 3H), 0.92 (t, J = 7.5, 3H). 13C NMR (101 MHz, CDCl3) į 136.14, 134.05, 
129.03, 128.04, 127.69, 126.77, 77.45, 33.69, 27.10, 8.08. [Į]D20 =  +2.2 (c = 0.9, 
CHCl3). HRMS (ESI+, m/z): calcd for C12H15BrO-OH [M-OH]+: 237.0279; found: 
237.0274. Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel 
AD-H column, n-heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, retention times 
(min): 29.8 (minor) and 31.7 (major). The absolute configuration of this compound 
is assumed to be (R), analogous to the other products. 
 
(+)-(Z)-2-bromo-1-(4-bromophenyl)-5-ethyl-3-methylhept-1-en-3-ol (3ka) 
 Using method A: Reaction was performed with ligand L1 and 
(2-ethylbutyl)magnesium bromide. Colorless oil, obtained as a 97:2:1 mixture of 
3ka, 4ka, and 5ka after column chromatography (SiO2, n-pentane:Et2O 90:10), 2m 
[94% yield, 92% ee].  1H NMR (400 MHz, CDCl3) į 7.48 (dd, J = 8.7, 2.0, 2H), 7.40 
(d, J = 8.6, 2H), 7.15 (s, 1H), 1.92 (s, 1H), 1.83 (dd, J = 14.5, 3.7, 1H), 1.69 – 1.60 
(m, 1H), 1.57 (s, 3H), 1.47 – 1.31 (m, 5H), 0.86 (t, J = 7.1, 6H). 13C NMR (101 
MHz, CDCl3) į 135.68, 135.15, 131.23, 130.62, 125.29, 121.59, 77.67, 43.70, 
36.43, 28.68, 26.50, 10.80. [Į]D20 =  +16.7 (c = 3.5, CHCl3). HRMS (ESI+, m/z): 
calcd for C16H22Br2O-OH [M-OH]+: 371.0010; found: 371.0013. Enantiomeric 
excess was determined by chiral HPLC analysis, Chiralcel AD-H column, n-
heptane/i-PrOH 99:1, 40 °C, detection at 240 nm, retention times (min): 26.2 














 Using method B: Reaction was performed with ligand L1 and 
(2-ethylbutyl)magnesium bromide. Colorless oil obtained as a 98:1:1 mixture of 3la, 
4la, and 5la after column chromatography (SiO2, n-pentane:Et2O 90:10), 2n [96% 
yield, 94% ee]. 1H NMR (400 MHz, CDCl3) į 7.61 (s, 4H), 7.27 (s, 1H), 1.90 (s, 
1H), 1.86 (dd, J = 14.5, 3.9, 1H), 1.65 (dd, J = 14.5, 4.8, 1H), 1.59 (s, 3H), 1.46 – 
1.32 (m, 5H), 0.86 (t, J = 7.2, 6H). 13C NMR (101 MHz, CDCl3) į 139.98, 136.90, 
129.25, 125.28, 124.99, 77.72, 43.65, 36.34, 28.78, 26.50, 10.78. [Į]D20 =  +11.3 (c 
= 1.8, CHCl3). HRMS (ESI+, m/z): calcd for C17H22BrF3O-OH [M-OH]+: 361.0779; 
found: 361.0776. Enantiomeric excess was determined by chiral HPLC analysis, 
Chiralcel AD-H column, n-heptane/i-PrOH 99:1, 40 °C, detection at 240 nm, 
retention times (min): 17.9 (major) and 21.2 (minor).  
 
(+)-(Z)-2-bromo-1-cyclohexyl-3,5-dimethylhex-1-en-3-ol (3mb) 
Using method B: Reaction was performed with ligand L1 and 
iBuMgBr. Colorless oil obtained as a 98:2:0 mixture of 3mb, 4mb, and 5mb after 
column chromatography (SiO2, n-pentane:Et2O 90:10), 2o [95% yield, 94% ee]. 1H 
NMR (400 MHz, CDCl3) į 5.85 (d, J = 8.6, 1H), 2.48 – 2.37 (m, 1H), 1.85 (s, 1H), 
1.68 (m, 7H), 1.56 (m, 1H), 1.44 (s, 3H), 1.35 – 1.24 (m, 2H), 1.24 – 1.05 (m, 3H), 
0.93 (2d, J = 6.4, 6H). 13C NMR (101 MHz, CDCl3) į 133.32, 132.64, 76.58, 49.15, 
40.60, 31.76, 28.14, 25.96, 25.65, 24.44, 24.14. [Į]D20 =  +1.6 (c = 1.9, CHCl3).  
HRMS (ESI+, m/z): calcd for C14H25BrO -OH [M-OH]+: 271.1062; found: 271.1065. 
Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel AD-H 
column, n-heptane/i-PrOH 99:1, 40 °C, detection at 240 nm, retention times (min): 






Br Using method A: Reaction was performed with ligand L1 and 
(cyclohexylmethyl)magnesium bromide. Colorless oil, obtained as a 97:2:1 mixture 
of 3me, 4me, and 5me after column chromatography (SiO2, n-pentane:Et2O 
90:10), 2p [94% yield, 94% ee]. 1H NMR (400 MHz, CDCl3) į 5.84 (d, J = 8.6, 1H), 
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2.49 – 2.36 (m, 1H), 1.84 (s, 1H), 1.77 – 1.59 (m, 10H), 1.52 (dd, J = 14.3, 5.7, 
1H), 1.43 (s, 3H), 1.39 – 1.04 (m, 10H), 0.96 (m, 2H). 13C NMR (101 MHz, CDCl3) 
į 133.29, 132.64, 76.63, 47.88, 40.58, 34.74, 33.94, 31.72, 28.09, 26.39, 25.97, 
25.65. [Į]D20 =  +1.8 (c = 1.5, CHCl3). HRMS (ESI+, m/z): calcd for C17H29BrO -OH 
[M-OH]+: 311.1375; found: 311.1372. Enantiomeric excess was determined by 
chiral HPLC analysis, Chiralcel AD-H column, n-heptane/i-PrOH 99:1, 40 °C, 
detection at 240 nm, retention times (min): 19.1 (minor) and 19.7 (major).  
 
Application of the methodology: access to a chiral dihydrofuran 
(+)-(E)-3-Benzylidene-6-ethyl-4-methyl-1-phenyloct-1-yn-4-ol (7): 
 7 was prepared from compound 3jc on 0.3 mmol scale, according 
to a literature procedure.54 Colorless oil, obtained after column chromatography 
(SiO2, n-pentane:Et2O 90:10), 7 [92% yield, 96% ee]. 1H NMR (201 MHz, CDCl3) į 
8.02 – 7.84 (m, 2H), 7.59 – 7.26 (m, 8H), 7.07 (s, 1H), 2.06 – 1.88 (m, 2H), 1.78 (s, 
1H), 1.60 (s, 3H), 1.54 – 1.28 (m, 5H), 0.88 (t, J = 7.2, 3H), 0.72 (t, J = 7.1, 3H). 13C 
NMR (101 MHz, CDCl3) į 136.56, 131.81, 131.30, 129.17, 128.85, 128.44, 128.37, 
128.18, 128.07, 127.92, 123.43, 97.41, 88.20, 76.45, 44.69, 36.28, 29.33, 26.86, 
10.79. [Į]D20 =  +51.6 (c = 1.8, CHCl3).  HRMS (ESI+, m/z): calcd for C24H28O-OH 
[M-OH]+: 315.2113; found: 315.2107. Enantiomeric excess was determined by 
chiral HPLC analysis, Chiralcel AD-H column, n-heptane/i-PrOH 98:2, 40 °C, 
detection at 240 nm, retention times (min): 35.0(major) and 41.3(minor). The 




 8 prepared from compound 7 on 0.25 mmol scale, according to 
a literature procedure.43 Colorless oil obtained after column chromatography (SiO2, 
n-pentane), 8 [91% yield]. 1H NMR (400 MHz, CDCl3) į 7.82 – 7.65 (m, 2H), 7.37 
(m, 7H), 7.17 (t, J = 7.1, 1H), 6.64 (s, 1H), 5.73 (s, 1H), 1.76 (m, 2H), 1.50 (s, 3H), 





162.95, 150.53, 139.06, 130.74, 129.25, 128.45, 128.41, 127.49, 125.66, 125.42, 
111.64, 98.68, 92.00, 44.49, 36.37, 28.06, 26.78, 26.51, 10.85. [Į]D20 =  +37.7 (c = 
0.9, CHCl3). HRMS (ESI+, m/z): calcd for C24H28O+H [M+H]+: 333.2140; found: 
333.2213. The absolute configuration of this compound is assumed to be (R), 





 Using method A: reaction was performed with ligand L1 and (2-
ethylbutyl)magnesium bromide. Colorless oil, obtained as a 13ac after column 
chromatography (SiO2, n-pentane:Et2O 90:10), [23% yield, 2% ee]. 1H NMR (400 
MHz, CDCl3) į 7.31 (dd, J = 8.0, 6.8, 2H), 7.26 – 7.19 (m, 3H), 2.81 –2.71  (dd, J = 
13.2, 13.2, 2H), 1.45 (d, J = 5.4, 2H), 1.43 – 1.38 (m, 5H), 1.19 (s, 1H) 1.13 (s, 3H), 
0.86 (2t, J = 7.5, 6H). 13C NMR (101 MHz, CDCl3) į 137.56, 130.65, 128.13, 
126.39, 73.04, 49.14, 45.55, 36.08, 27.15, 26.96, 10.89. HRMS (ESI+, m/z): calcd 
for C15H24O-OH [M-OH]+: 203.1800; found: 203.1791. Enantiomeric excess was 
determined by chiral HPLC analysis, Chiralcel AD-H column, n-heptane/i-PrOH 
98:2, 40 °C, detection at 240 nm, retention times (min): 13.6 (major) and 15.2 
(minor). 
 
 2-Cyclohexyl-4-ethylhexan-2-ol (13bc): 
 
Using method A: Reaction was performed with ligand L1 and (2-
ethylbutyl)magnesium bromide. No reaction was observed to the desired product. 
 
(+)-(R)-4-Ethyl-2-phenylhexan-2-ol (13cc): 
 Using method A: Reaction was performed with ligand L1 and (2-
ethylbutyl)magnesium bromide. Colorless oil obtained as a 13bc after column 
chromatography (SiO2, n-pentane:Et2O 90:10), [96% yield, 84% ee]. 1H NMR (400 
MHz, CDCl3) į 7.44 (dd, J = 8.4, 1.2, 2H), 7.33 (dd, J = 10.4, 4.9, 2H), 7.25 – 7.18 
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(m, 1H), 1.72 (d, J = 5.4, 2H), 1.62 (s, 1H), 1.56 (s, 3H), 1.26 – 1.11 (m, 5H), 0.74 
(dt, J = 25.1, 7.2, 6H). 13C NMR (101 MHz, CDCl3) į 127.98, 126.39, 124.83, 
75.20, 47.53, 36.17, 30.74, 26.67, 10.59. [Į]D20 =  +12.0 (c = 0.3, CHCl3).  HRMS 
(ESI+, m/z): calcd for C14H22O-OH [M-OH]+: 189.1644; found: 189.1638. 
Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel OJ 
column, n-heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, retention times (min): 
5.3 (major) and 6.0 (minor). The absolute configuration of this compound is 
assumed to be (R), analogous to the other products.55 
 
(E)-2,3-Dimethyl-1-phenylhept-1-en-3-ol (3bn): 
 Using method A: Reaction was performed with ligand L1 and (n-
butyl)2Mg. Colorless oil obtained as a 97:1:2 mixture of 3bn, 4bn, and 5bn  after 
column chromatography (SiO2, n-pentane:Et2O 90:10), 3bn [94% yield, 2% ee]. 1H 
NMR (400 MHz, CDCl3) į 7.33 (t, J = 7.6, 2H), 7.22 (dd, J = 15.1, 7.7, 3H), 6.66 (s, 
1H), 1.84 (s, 3H), 1.77 – 1.56 (m, 3H), 1.54 (s, 1H),  1.41 (s, 3H), 1.38 – 1.16 (m, 
3H), 0.99 – 0.78 (t, J = 7.1, 3H). 13C NMR (101 MHz, CDCl3) į 143.33, 138.50, 
129.04, 128.00, 126.07, 123.38, 76.04, 40.26, 27.83, 26.06, 23.07, 14.67, 14.09. 
HRMS (ESI+, m/z): calcd for C15H22O-OH [M-OH]+: 201.1644; found: 201.1639. 
Enantiomeric excess was determined by chiral HPLC analysis, Chiralcel AD-H 
column, n-heptane/i-PrOH 98:2, 40 °C, detection at 240 nm, retention times (min): 
18.3 (major) and 19.9 (minor). The absolute configuration of this compound is 
assumed to be (R), analogous to the other products. 
 
Formation of a single copper complex: 
The copper based catalyst employed in the reactions was normally prepared in situ 
by mixing L1 with CuBr·SMe2 in 1.1:1 ratio. Formation of a single copper complex 
was anticipated upon mixing both reagents. This was supported by both 1H and 31P 
NMR spectroscopy upon mixing L1 and CuBr·SMe2 in 1:1 ratio. NMR spectra 
showed complete disappearance of the signals corresponding to the free ligand L1 
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